BCLI vs CHEK
Comparison between Brainstorm Cell Therapeutics Inc (BCLI, Company) and Check-Cap Ltd (CHEK, Company).
Both BCLI and CHEK are from the Healthcare sector.
5-Year PerformanceCHEK has outperformed BCLI, delivering a return of -27.2% compared to -56.8%
BCLI vs CHEK - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BCLI vs CHEK - Historical Returns
Returns include dividend reinvestment.
BCLI vs CHEK - Annual Returns (2003 - 2026)
Returns include dividend reinvestment.
| Year | BCLI | CHEK |
|---|---|---|
| 2026 | +38.64% | N/A |
| 2025 | -74.16% | +39.39% |
| 2024 | -46.90% | -50.75% |
| 2023 | -83.65% | -14.75% |
| 2022 | -60.86% | -83.99% |
| 2021 | -11.89% | -53.47% |
| 2020 | +9.83% | -73.41% |
| 2019 | +23.70% | -24.23% |
| 2018 | -2.74% | -80.31% |
| 2017 | +53.13% | -63.60% |
| 2016 | -13.90% | +16.92% |
| 2015 | -61.87% | -68.91% |
| 2014 | +67.01% | N/A |
| 2013 | -25.00% | N/A |
| 2012 | -8.33% | N/A |
| 2011 | +5.00% | N/A |
| 2010 | -26.92% | N/A |
| 2009 | +224.98% | N/A |
| 2008 | -89.83% | N/A |
| 2007 | +132.15% | N/A |
| 2006 | -49.09% | N/A |
| 2005 | -77.50% | N/A |
| 2004 | +99.00% | N/A |
| 2003 | +212.22% | N/A |
BCLI vs CHEK Drawdown Comparison
The maximum drawdown for BCLI was -99.94%, occurring on Feb 17, 2026. This drawdown has not yet recovered.
The maximum drawdown for CHEK was -99.96%, occurring on Dec 19, 2024. This drawdown has not yet recovered.
The current BCLI drawdown is -99.89%. The current CHEK drawdown is -99.89%.
| Rank | BCLI | CHEK |
|---|---|---|
| #1 | -99.94% Jan 7, 2005 - Feb 17, 2026 | -99.96% Mar 5, 2015 - Dec 19, 2024 |
| #2 | -50.00% Oct 21, 2003 - Nov 4, 2004 | N/A |
| #3 | -9.00% Dec 15, 2004 - Jan 6, 2005 | N/A |
| #4 | -7.27% Oct 3, 2003 - Oct 9, 2003 | N/A |
| #5 | -4.64% Nov 26, 2004 - Dec 13, 2004 | N/A |
| #6 | -2.29% Sep 22, 2003 - Oct 3, 2003 | N/A |
Correlation
Correlation between BCLI and CHEK is 0.03 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks